Pathogenesis of TSC2-Related Tumors

$69,289R01FY2007CANIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 23376645 Paper 21479224 Paper 20813961 Paper 20042714 Paper 18511518 Paper 17521703 Paper 16707451 Paper 15579026 Paper 15093748 Paper 14566857 Paper 12511557 Paper 12384518 Paper 12040899 Paper 11290735 Paper 11259412

Abstract

Principal Investigator/Program Director (Last, first, middle): Yeung, Raymond The PI3K/AKT/mTOR pathway has been implicated in many human cancers. However, the contribution and mechanism of mTOR in the pathogenesis of these tumors remains poorly understood. Over the last funding period, a wealth of genetic and biochemical studies have identified a

View original record on NIH RePORTER →